- A major analysis of 196 subjects showed that the vaccine has an effective rate of 94.1%.
- Pfizer and BioNTech SE have already submitted applications for similar vaccines in the United States earlier this month.
- This year's "Black Friday" US online transaction volume reached $9 billion.
Moderna Inc, is planning to apply for emergency authorization for its new coronavirus vaccine in the United States and Europe on Monday. A previous analysis showed that the company’s vaccine is very effective in preventing new coronavirus infections without serious safety issues.
According to the company’s statement, a major analysis of 196 subjects showed that the vaccine has an effective rate of 94.1%, which is consistent with the preliminary analysis results released earlier this month.
All 30 severe cases observed in the trial were placebo-injected subjects.
”We respectfully decline to comment at this time,” Abigail Capobianco, a spokeswoman for the FDA, said in an email.
The vaccine is expected to be one of the first COVID-19 vaccines approved in the United States. Pfizer and BioNTech SE have already submitted applications for similar vaccines in the United States earlier this month, and will undergo regulatory review and evaluation before the Moderna vaccine.
“We have been working nonstop in the last few weeks to get the vaccine data ready to submit to regulators,” Stephane Bancel, Moderna’s chief executive officer, said in an interview. “We are ready today to ship the vaccine,” Bancel said. “We have millions of doses ready, we have more and more every couple days.”
Moderna said it plans to apply for an emergency use authorization in the United States on Monday and a conditional marketing authorization in Europe. The company said that consultants from the U.S. Food and Drug Administration (FDA) may evaluate the data at a public meeting on December 17. A similar evaluation of Pfizer vaccine is expected to be carried out a week earlier.
Bancel said that emergency use authorization may be obtained as soon as 24 to 72 hours after the December 17 meeting. If authorized, all Moderna inventory will be sent to the federal government. Bancel said that 20 million doses of vaccine are expected to be delivered in the United States by the end of this year.
Moderna has reached an agreement including providing 100 million doses of vaccine to the United States and 80 million doses to the European Union.
“Black Friday”: Online Transaction Volume Breaks Record
“Black Friday” is the day after Thanksgiving in the United States, marking the beginning of the Christmas shopping season. With the rise of online shopping, more consumers choose to place online orders during the “Black Friday” period.
This year, the new coronavirus epidemic has intensified this trend. Adobe Analytics tracks online consumption and estimates that this year’s “Black Friday” US online transaction volume reached $9 billion.
This breaks the record of last year’s “Black Friday” online transaction volume of $7.4 billion, a year-on-year increase of 22%. Toys, headphones and TVs are selling well online.
Adobe Analytics also said that the online transaction volume of large retailers, such as Wal-Mart, the largest chain retailer in the United States, and Target Department Store, a general merchandise chain, during the “Black Friday” period, increased by 403% compared to the daily average in October. Quotient rose 349%.
The analysis company predicts that the U.S. online transaction volume record may be refreshed on the 30th, with an estimated transaction volume of $10.8 billion to $12.7 billion.